Gerstmann-Sträussler-Scheinker Disease

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Second Edition

Volumn , Issue , 2011, Pages 364-377

  Ghetti, Bernardino ^a   Tagliavini, Fabrizio ^b   Kovacs, Gabor G ^c   Piccardo, Pedro ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Amyloid; Neuritic plaques; Neurofibrillary tangles; Prion disease; Prion protein; PRNP; Spongiform encephalopathy; Tau protein; Transmissibility

Indexed keywords

EID: 84883804027     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444341256.ch37     Document Type: Chapter

References (61)

1. Ghetti B, Dlouhy SR, Giaccone G, et al. Gerstmann-Sträussler-Scheinker disease and the Indiana Kindred. Brain Pathol 1995; 5: 61-75.
2. Piccardo P, Liepnieks JJ, William A, et al.l. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. Am J Pathol 2001; 158: 2201-2207.
3. Piccardo P, Dlouhy SR, Lievens PMJ, et al.l. Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 1998; 57: 979-988.
4. Piccardo P, Seiler C, Dlouhy SR, et al.l. Protease K resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker Disease (Indiana kindred). J Neuropathol Exp Neurol 1996; 55: 1157-1163.
5. Tagliavini F, Lievens PM, Tranchant C, et al.l. A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Straussler-Scheinker disease A117V. J Biol Chem 2001; 276: 6009-6015.
6. Tagliavini F, Prelli F, Ghiso J, et al.l. The amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11-Kd degradation product of PrP that starts at position 58 of the cDNA-deduced PrP sequence. EMBO J 1991; 10: 513-519.
7. Tagliavini F, Prelli F, Porro M, et al.l. Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish Kindreds) express only PrP peptides encoded by the mutant allele. Cell 1994; 79: 695-703.
8. Ghetti B, Piccardo P, Frangione B, et al.l. Prion protein amyloidosis. Brain Pathol 1996; 6: 127-145.
9. Dimitz L. Bericht des Vereines für Psychiatrie und Neurologie in Wien. (Vereinsjahr 1912/13). Sitzung vom 11. Juni 1912. Jahrb Psychiatr Neurol 1913; 34: 384.
10. Gerstmann J. Ü ber ein noch nicht beschriebenes Reflexphanomen bei einer Erkrankung des zerebellaren Systems. Wien Med Wochenschr 1928; 78: 906-908.
11. Gerstmann J, Sträussler E, Scheinker I. Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems. Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z Gesamt Neurol Psychiat 1936; 154: 736-762.
12. Seitelberger F. Sträussler's disease. Acta Neuropathol 1981; 7: 341-343.
13. Masters CL, Gajdusek DC, Gibbs CJ. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaques deposition in the virus induced spongiform encephalopathies. Brain 1981; 104: 559-588.
14. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 1987; 57: 230-236.
15. Ghetti B, Farlow M, Conneally M, et al.l. Amyloid plaques and neurofi-brillary tangles of Gerstmann-Sträussler-Scheinker disease. Neurology 1988; 38 (Suppl. 1): 266.
16. Gambetti P, Petersen RB, Parchi P, et al.l. Inherited Prion Diseases. In: Prusiner SB (ed) Prion Biology and Diseases. New York: Cold Spring Harbor Laboratory Press, 1999, pp. 509-583.
17. Kretzschmar HA, Honold G, Seitelberger F, et al.l. Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker. Lancet 1991; 337: 1160.
18. Hsiao K, Baker HF, Crow TJ, et al.l. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 1989; 338: 342-345.
19. Dlouhy SR, Hsiao K, Farlow MR, et al.l. Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene. Nat Genet 1992; 1: 64-67.
20. Prusiner SB. An introduction to prion biology and diseases. In: Prusiner SB (ed) Prion Biology and Diseases. New York: Cold Spring Harbor Laboratory Press, 1999, pp. 1-67.
21. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24: 519-550.
22. Furukawa H, Kitamoto T, Tanaka Y, Tateishi J. New variant prion protein in a Japanese family with Gerstmann-Sträussler syndrome. Mol Brain Res 11995; 30: 385-388.
23. Webb TE, Poulter M, Beck J, et al.l. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 2008; 131: 2632-2646.
24. Kepe V, Ghetti B, Farlow MR, et al.l. PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease. Brain Pathol 2010; 20: 419-430.
25. Young K, Clark HB, Piccardo P, Dlouhy SR, Ghetti B. Gerstmann-Sträussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129. Mol Brain Res 1997; 44: 147-150.
26. Kitamoto T, Amano N, Terao Y, et al.l. A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann Neurol 1993; 34: 808-813.
27. Yamada M, Itoh Y, Inaba A, et al.l. An inherited prion disease with a PrP P105L mutation: clinicopathologic and PrP heterogeneity. Neurology 1999; 53: 181-188.
28. Iwasaki Y, Kizawa M, Hori N, Kitamoto T, Sobue G. A case of Gerstmann-Sträussler-Scheinker syndrome with the P105L prion protein gene mutation presenting with ataxia and extrapyramidal signs without spastic paraparesis. Clin Neurol Neurosurg 2009; 111: 606-609.
29. Tunnell E, Wollman R, Mallik S, Cortes CJ, Dearmond SJ, Mastrianni JA. A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation. Neurology 2008; 71(18): 1431-1438.
30. Nochlin D, Sumi SM, Bird TD, et al.l. Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Sträussler syndrome. Neurology 1989; 39: 910-918.
31. Tranchant C, Dohura K, Warter JM, et al.l. Gerstmann-Sträussler-Scheinker disease in an Alsatian family-clinical and genetic studies. J Neurol Neurosurg Psychiatry 1992; 55: 185-187.
32. Mallucci GR, Campbell TA, Dickinson A, et al.l. Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain 1999; 122: 1823-1837.
33. Panegyres PK, Toufexis K, Kakulas BA, et al.l. A new mutation [G131V] linked to Gerstmann-Sträussler-Scheinker disease. Arch Neurol 2001; 58: 1899-1902.
34. Hilton DA, Head MW, Singh VK, Bishop M, Ironside JW. Familial prion disease with a novel serine to isoleucine mutation at codon 132 of prion protein gene (PRNP). Neuropathol Appl Neurobiol 2009; 35: 111-115.
35. Rowe DB, Lewis V, Needham M, et al.l. Novel prion protein gene mutation presenting with subacute PSP-like syndrome. Neurology 2007; 68: 868-870.
36. Butefisch CM, Gambetti P, Cervenakova L, Park KY, Hallett M, Goldfarb LG. Inherited prion encephalopathy associated with the novel PRNP H187R mutation: a clinical study. Neurology 2000; 55: 517-522.
37. Farlow MR, Yee RD, Dlouhy SR, Conneally PM, Azzarelli B, Ghetti B. Gerstmann-Sträussler-Scheinker disease: I. Extending the clinical spectrum. Neurology 1989; 39: 1446-1452.
38. Ghetti B, Tagliavini F, Giaccone G, et al.l. Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Mol Neurobiol 1994; 8: 41-48.
39. Hsiao K, Dlouhy SR, Farlow MR, et al.l. Mutant prion protein in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nat Genet 1992; 1: 68-71.
40. Alzualde A, Indakoetxea B, Ferrer I, et al.l. A novel PRNP Y218N mutation in Gerstmann-Sträussler-Scheinker disease with neurofibrillary degeneration. J Neuropathol Exp Neurol 2010; 69: 789-800.
41. Jansen C, Parchi P, Capellari S, et al.l. Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol 2010; 119(2): 189-197.
42. Liberski PP, Barcikowska M, Cervenakova L, et al.l. A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler-Scheinker phenotype but no alterations in the PRNP gene. Acta Neuropathol 1998; 96: 425-430.
43. Liberski PP, Bratosiewicz J, Barcikowska M, et al.l. A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler-Scheinker phenotype but no alterations in the PRNP gene. Acta Neuropathol 2000; 100: 233-234.
44. Ghetti B, Piccardo P, Spillantini MG, et al.l. Vascular variant of prion protein cerebral amyloidosis with t-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 1996; 93: 744-748.
45. Jayadev S, Nochlin D, Poorkaj P, et al.l. Familial prion disease with ADlike tau pathology and clinical phenotype. Ann Neurol 2010; in press.
46. Holton JL, Mead S, Gandhi S, et al.l. Clinicopathological observations associated with a novel truncation mutation of PRNP. Neuropath Appl Neurobiol 2010; 36(Suppl 1): 2-3.
47. Ironside JW, Ghetti B, Head MW, Piccarod P, Will RG. Prion diseases. In: Love S, Louis DN, Ellison DW (eds) Greenfield's Neuropathology. 8th edn. London: Hodder Arnold, 2008, pp. 1197-1274.
48. Colucci M, Moleres FJ, Xie ZL, et al.l. Gerstmann-Sträussler-Scheinker: a new phenotype with "curly" PrP deposits. J Neuropathol Exp Neurol 2006; 65: 642-651.
49. Ghetti B, Tagliavini F, Masters CL, et al.l. Gerstmann-Sträussler-Scheinker disease: II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 1989; 39: 1453-1461.
50. Ghetti B, Gambetti P. Human Prion Diseases. In: Mattson MP (ed) Advances in Cell Aging and Gerontology, Volume 3: Genetic Aberrancies and Neurodegenerative Disorders. Greenwich, CT: Jai Press, 1999, pp. 135-187.
51. Tagliavini F, Prelli F, Verga L, et al.l. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 1992; 90: 9678-9682.
52. Wadsworth JD, Joiner S, Linehan JM, et al.l. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain 2006; 129: 1557-1569.
53. Swietnicki W, Petersen RB, Gambetti P, Surewicz WK. Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem 1998; 273: 31048-31052.
54. Chesebro B, Race B, Meade-White K, et al.l. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog 2010; 6: e1000800.
55. Parchi P, Chen SG, Brown P, et al.l. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci USA 1998; 95: 8322-8327.
56. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al.l. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-529.
57. Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 1990; 250: 1587-1590.
58. Manson JC, Jamieson E, Baybutt H, et al.l. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 1999; 18: 6855-6864.
59. Yang W, Cook J, Rassbach B, Lemus A, DeArmond SJ, Mastrianni JA. A new transgenic mouse model of Gerstmann-Sträussler-Scheinker syndrome caused by the A117V mutation of PRNP. J Neurosci 2009; 29: 10072-10080.
60. Piccardo P, Manson JC, King D, Ghetti B, Barron RM. Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc Natl Acad Sci USA 2007; 104: 4712-4717.
61. Chiesa R, Piccardo P, Biasini E, Ghetti B, Harris DA. Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities. J Neurosci 2008; 28: 13258-13267.